(PATH) Uipath - Overview
Sector: TechnologyIndustry: Software - Infrastructure | Exchange NYSE (USA) | Currency USD | Market Cap: 6.487m | Total Return -1.7% in 12m
Stock: Automation, Software, AI, Cloud
| Risk 5d forecast | |
|---|---|
| Volatility | 54.5% |
| Relative Tail Risk | -11.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.20 |
| Alpha | -22.52 |
| Character TTM | |
|---|---|
| Beta | 1.584 |
| Beta Downside | 1.415 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.58% |
| CAGR/Max DD | -0.24 |
EPS (Earnings per Share)
Revenue
Risks
Description: PATH Uipath March 03, 2026
UiPath Inc. (PATH) operates as a global leader in the robotic process automation (RPA) sector, providing an end-to-end platform designed to automate repetitive business tasks. The company’s software robots utilize artificial intelligence (AI), machine learning (ML), and natural language processing (NLP) to emulate human actions across user interfaces and APIs. This technology is primarily deployed through the Automation Cloud, which reduces infrastructure overhead for enterprise clients.
The business model follows a software-as-a-service (SaaS) structure, focusing on high-growth industries such as financial services, healthcare, and manufacturing. Within the Systems Software sub-industry, RPA tools are increasingly integrated with process mining capabilities, which allow organizations to analyze digital footprints to identify inefficiencies before deploying automation. This integration of AI and low-code functionality aims to enhance productivity by enabling seamless collaboration between human workers and digital assistants.
Headquartered in New York and founded in 2005, the company maintains a significant international presence with major operations in Romania and the United Kingdom. Investors looking for deeper fundamental insights may find further value in exploring the analysis available at ValueRay. The platform’s analytics suite also includes performance tracking and predictive insights to help organizations measure the return on investment for their automation deployments.
Headlines to watch out for
- Enterprise adoption of automation software drives recurring revenue growth
- AI and ML integration enhances platform capabilities and customer value
- Competition from established software vendors impacts market share
- Economic downturns reduce IT spending and automation project budgets
- Regulatory scrutiny on data privacy and AI ethics increases compliance costs
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 282.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 0.41 > 1.0 |
| NWC/Revenue: 83.11% < 20% (prev 107.7%; Δ -24.58% < -1%) |
| CFO/TA 0.12 > 3% & CFO 371.2m > Net Income 282.3m |
| Net Debt (-800.2m) to EBITDA (74.8m): -10.69 < 3 |
| Current Ratio: 2.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (545.3m) vs 12m ago -1.82% < -2% |
| Gross Margin: 83.25% > 18% (prev 0.83%; Δ 8.24k% > 0.5%) |
| Asset Turnover: 53.29% > 50% (prev 49.90%; Δ 3.39% > 0%) |
| Interest Coverage Ratio: -1.35 > 6 (EBITDA TTM 74.8m / Interest Expense TTM -42.8m) |
Altman Z'' -0.46
| A: 0.42 (Total Current Assets 2.24b - Total Current Liabilities 905.4m) / Total Assets 3.18b |
| B: -0.54 (Retained Earnings -1.71b / Total Assets 3.18b) |
| C: 0.02 (EBIT TTM 57.9m / Avg Total Assets 3.02b) |
| D: -1.52 (Book Value of Equity -1.67b / Total Liabilities 1.10b) |
| Altman-Z'' Score: -0.46 = B |
Beneish M -2.57
| DSRI: 0.95 (Receivables 580.7m/542.3m, Revenue 1.61b/1.43b) |
| GMI: 0.99 (GM 83.25% / 82.69%) |
| AQI: 1.74 (AQ_t 0.26 / AQ_t-1 0.15) |
| SGI: 1.13 (Revenue 1.61b / 1.43b) |
| TATA: -0.03 (NI 282.3m - CFO 371.2m) / TA 3.18b) |
| Beneish M-Score: -2.57 (Cap -4..+1) = A |
What is the price of PATH shares?
Over the past week, the price has changed by -11.36%, over one month by -0.37%, over three months by -36.56% and over the past year by -1.66%.
Is PATH a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 18
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the PATH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.8 | 29.2% |
| Analysts Target Price | 13.8 | 29.2% |
PATH Fundamental Data Overview March 25, 2026
P/E Forward = 14.5349
P/S = 4.0275
P/B = 3.0967
P/EG = 0.4151
Revenue TTM = 1.61b USD
EBIT TTM = 57.9m USD
EBITDA TTM = 74.8m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 70.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -800.2m USD (from netDebt column, last quarter)
Enterprise Value = 5.08b USD (6.49b + Debt 70.9m - CCE 1.47b)
Interest Coverage Ratio = -1.35 (Ebit TTM 57.9m / Interest Expense TTM -42.8m)
EV/FCF = 14.44x (Enterprise Value 5.08b / FCF TTM 352.2m)
FCF Yield = 6.93% (FCF TTM 352.2m / Enterprise Value 5.08b)
FCF Margin = 21.87% (FCF TTM 352.2m / Revenue TTM 1.61b)
Net Margin = 17.53% (Net Income TTM 282.3m / Revenue TTM 1.61b)
Gross Margin = 83.25% ((Revenue TTM 1.61b - Cost of Revenue TTM 269.8m) / Revenue TTM)
Gross Margin QoQ = 84.88% (prev 83.26%)
Tobins Q-Ratio = 1.60 (Enterprise Value 5.08b / Total Assets 3.18b)
Interest Expense / Debt = 25.57% (Interest Expense 18.1m / Debt 70.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 45.7m (EBIT 57.9m * (1 - 21.00%))
Current Ratio = 2.48 (Total Current Assets 2.24b / Total Current Liabilities 905.4m)
Debt / Equity = 0.03 (Debt 70.9m / totalStockholderEquity, last quarter 2.08b)
Debt / EBITDA = -10.69 (Net Debt -800.2m / EBITDA 74.8m)
Debt / FCF = -2.27 (Net Debt -800.2m / FCF TTM 352.2m)
Total Stockholder Equity = 1.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.34% (Net Income 282.3m / Total Assets 3.18b)
RoE = 15.32% (Net Income TTM 282.3m / Total Stockholder Equity 1.84b)
RoCE = 2.54% (EBIT 57.9m / Capital Employed (Total Assets 3.18b - Current Liab 905.4m))
RoIC = 2.59% (NOPAT 45.7m / Invested Capital 1.76b)
WACC = 11.64% (E(6.49b)/V(6.56b) * Re(11.55%) + D(70.9m)/V(6.56b) * Rd(25.57%) * (1-Tc(0.21)))
Discount Rate = 11.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.58%
[DCF] Terminal Value 66.11% ; FCFF base≈333.6m ; Y1≈331.3m ; Y5≈346.7m
[DCF] Fair Price = 9.56 (EV 3.60b - Net Debt -800.2m = Equity 4.40b / Shares 460.4m; r=11.64% [WACC]; 5y FCF grow -1.40% → 3.0% )
EPS Correlation: 69.33 | EPS CAGR: 147.0% | SUE: 1.56 | # QB: 1
Revenue Correlation: 89.08 | Revenue CAGR: 19.71% | SUE: 1.76 | # QB: 4
EPS next Quarter (2026-04-30): EPS=0.16 | Chg7d=+0.005 | Chg30d=+0.005 | Revisions Net=+7 | Analysts=19
EPS current Year (2027-01-31): EPS=0.80 | Chg7d=+0.036 | Chg30d=+0.036 | Revisions Net=+10 | Growth EPS=+10.9% | Growth Revenue=+9.1%
EPS next Year (2028-01-31): EPS=0.90 | Chg7d=+0.064 | Chg30d=+0.064 | Revisions Net=+12 | Growth EPS=+12.3% | Growth Revenue=+8.4%
[Analyst] Revisions Ratio: +0.64 (9 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.3% (Discount Rate 11.6% - Earnings Yield 4.3%)
[Growth] Growth Spread = +4.2% (Analyst 11.5% - Implied 7.3%)